Brought to you by:
EVS 2022: Study suggests lower rates of aortic rupture, mortality after TEVAR for uncomplicated TBAD in subacute phase compared to medical management
Thoracic endovascular aortic repair (TEVAR) carried out for uncomplicated type B aortic dissections (TBAD) saw worse mortality and aortic-related outcomes when performed in the acute phase compared to those treated in the subacute phase and those managed medically. That was…
VEITHsymposium to include world federation session
The World Federation of Vascular Societies (WFVS) is set to hold a session in November during the VEITHsymposium in New York City. The 90-minute session will be held from 5 to 6:30 p.m. Eastern Standard Time, on Friday, Nov. 18, at…
No time like the present: The moral imperative for advocacy in vascular surgery
“I’m so sorry but we have to cancel your surgery”—10 words any warm-blooded surgeon dreads uttering. This time around, it was not for the typical reasons. Our patients’ blood pressure wasn’t sky high in pre-op, and our case wasn’t being…
Systemic heparin during TEVAR deemed safe for selected traumatic brain injury patients
The use of systemic heparin during thoracic endovascular aneurysm repair (TEVAR) for blunt thoracic aortic injuries (BTAI) appears to be safe in selected patients with traumatic brain injury (TBI), a new study presented at the 2022 Vascular Annual Meeting (VAM)…
Complex TAAA: US ARC IDE registry reports better survival vs. real-world data after endovascular repair
Patients treated in Food and Drug Administration (FDA)-approved investigational device exemption (IDE) trials for complex thoracoabdominal aortic aneurysms (TAAAs) in the U.S. Aortic Research Consortium (ARC) had better 30-day and one-year survival compared with those recorded in the real-world Vascular…
How an aortic ally can help physicians optimize patient outcomes
This advertorial is sponsored by Gore. The aorta is special. As one of the most complex and critically important vessels of the vascular system, the aorta presents unique challenges. As such, it deserves an investment in constant and specialized care…
Study suggests more proximal landing zone is preferred for TEVAR of acute type B aortic dissections
A review evaluating the results of thoracic endovascular aortic repair (TEVAR) following acute type B aortic dissection suggests most patients have less than 2cm of proximal healthy descending thoracic aorta. In patients treated for complicated acute type B aortic dissection,…
Guidelines recognize potential role for earlier endovascular treatment of uncomplicated type B aortic dissection
New clinical practice guidelines published today aim to act as “guard rails” to determine the treatment options and best practices for managing patients with type B aortic dissection. An important update in the document is the potential for earlier endovascular…
Physicians, industry urged to tackle multifactorial stroke risk following thoracic endovascular procedures
As evidence builds on the importance of reducing the risk of stroke by removing residual air prior to thoracic endovascular aortic repair (TEVAR) procedures, the onus will be on surgeons and device manufacturers to minimize this risk, attendees of CX…
RelayPro thoracic stent graft approved by FDA
Terumo Aortic today (Friday, Aug. 6) announced that the Food and Drug Administration (FDA) has granted approval of the RelayPro thoracic stent-graft system for sale in the United States for the treatment of patients with thoracic aortic aneurysms (TAAs) and…